Genopole
Overview
Genopole is France's first biocluster dedicated to supporting research and innovation in genomics, biotherapies, and synthetic biology, as well as fostering the development of biotechnology companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Watchfrog | May 2008 | Series A | Co-investor |
| Alt Biotech | Nov 2023 | Debt | Co-investor |
| Papilio.bio | Oct 2024 | Accelerator | Co-investor |
| 5h45 | - | Accelerator | Co-investor |
| Skite Solar | Oct 2025 | Accelerator | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Genopole based?
Genopole is headquartered in France.
When was Genopole founded?
Genopole was founded in 1998.
How many portfolio companies does Genopole have?
Genopole has 8 portfolio companies in Caplight's dataset.
What are some companies in Genopole's portfolio?
Portfolio companies visible on Caplight include Watchfrog, Alt Biotech, Papilio.bio, 5h45, Skite Solar.
What was Genopole's most recent investment shown here?
Genopole's most recent investment in this portfolio sample was in Skite Solar in 2025.
What sectors does Genopole focus on?
Genopole focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Energy & Sustainability, Energy & Sustainability, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Genopole focus on?
Stage focus information for Genopole is not publicly available.